Comparative evaluation of dexmedetomidine with clonidine as premedication for attenuation of hemodynamic responses during laryngoscopy and endotracheal intubation under general anesthesia

Salony Agarwal; Kumkum Gupta; V. P. Singh; Deepak Sharma; M. N. Pandey

doi:10.18203/2320-6012.ijrms20162928

Authors

Salony Agarwal Department of Anaesthesiology and Critical care, Subharti Medical College, Swami Vivekanand University, NH-58. By Pass Road, Meerut, Uttar Pradesh
Kumkum Gupta Department of Anaesthesiology and Critical care, Subharti Medical College, Swami Vivekanand University, NH-58. By Pass Road, Meerut, Uttar Pradesh
V. P. Singh Department of Anaesthesiology and Critical care, Subharti Medical College, Swami Vivekanand University, NH-58. By Pass Road, Meerut, Uttar Pradesh
Deepak Sharma Department of Anaesthesiology and Critical care, Subharti Medical College, Swami Vivekanand University, NH-58. By Pass Road, Meerut, Uttar Pradesh
M. N. Pandey Department of Anaesthesiology and Critical care, Subharti Medical College, Swami Vivekanand University, NH-58. By Pass Road, Meerut, Uttar Pradesh

DOI:

https://doi.org/10.18203/2320-6012.ijrms20162928

Keywords:

Dexmedetomidine, Clonidine, Hemodynamic response

Abstract

Background: Direct laryngoscopy and tracheal intubation predictably leads to tachyarrhythmia and hypertension which are usually transient and variable, but these changes may be fatal in high risk patients. These hemodynamic responses can be attenuated by appropriate premedication. Dexmedetomidine and clonidine, alpha- 2 adrenergic agonist, might do so. The present study was aimed to compare these drugs for attenuation of hemodynamic responses.

Methods: Sixty adult consented patients of ASA grade I and II between 18-58 yrs of age of either sex were randomly allocated into two equal groups of 30 patients each by computer generated random number table. They were administered either dexmedetomidine (Group A) or clonidine (Group B) in dose of 1μg.kg-1 intravenously as premedication. Hemodynamic changes during laryngoscopy and intubation were primary end points and any side effects due to drugs were observed as secondary end points.

Results: After propofol induction there was more fall in heart rate in patients of dexmedetomidine group as compared to clonidine group but with statistically non-significant difference (p value>0.05). After laryngoscopy and intubation, hemodynamic variations were more in patients of clonidine group than in dexmedetomidine group with statistically significant difference (p value<0.05). Bradycardia (HR<50/min) was observed in one patient of dexmedetomidine group and two patients in clonidine group, five minutes after intubation. Intraoperative hypotension was observed in one patient of dexmedetomidine group and in two patients of clonidine group.

Conclusions: Dexmedetomidine premedication in dose of 1 μg.kg-1 provided more stable hemodynamics during induction with propofol and following laryngoscopy and intubation as compared to clonidine.

Metrics

Metrics Loading ...

References

Bruder N, Ortega D, Granthil C. Consequences and prevention methods of hemodynamic changes during laryngoscopy and intratracheal intubation. Ann fr Anesth Reanim. 1992;11:57-71.

Reid LC, Brace DE. Irritation of the respiratory tract and its reflex effect on heart. Surg Gynae Obstet. 1940;70:157-62.

Singh H, Vichitvejpaisal P, Gaines GY, White PF. Comparative effect of lidocaine, esmolol and NTG in modifying the hemodynamic response to laryngoscopy and intubation. Clin Anaesth. 1995;7:1155-8.

Chraemmer JA¸ rgensen B, Hertel S, Carlsen PF, Bjerre-Jepsen K. Catecholamine response to laryngoscopy and intubation. The influence of three different drug combinations commonly used for induction of anaesthesia. Anaesthesia. 1992;47(9):750-6.

Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology. 1992;77:1134-42.

Sudheesh K, Harsoor SS. Dexmedetomidine in anaesthetic practice: A wonder drug? Ind J Anaesth 2011;55:323-4.

Ebert T, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000;93:382-94.

Saoyroolu AE, Celik M, Orhon Z, Yüzer S, Sen B. Different doses of dexmedetomidine on controlling hemodynamic responses to tracheal intubation. The Internet Journal of Anesthesiology. 2010;27:2.

Varshali MK, Sushma L, Ramesh Naphade. Dexmedetomidine attenuates the sympathoadrenal response to tracheal intubation and reduces perioperative anaesthetic requirement. Ind J Anesth. 2011;55:352-7.

Zalunardo MP, Zollinger A, Spahn DR, Seifert B, Radjaipour M, Gautschi K, et al. Effects of intravenous and oral clonidine on hemodynamic and plasma-catecholamine response due to endotracheal intubation. J Clin Anesth. 1997;9:143-7.

Scheinin H, Virtanen R, MacDonald E, Lammintausta R, Scheinin M. Dexmedetomidine, a novel alpha 2-adrenoceptor agonist: a review of its pharmacodynamic effects. Prog Neuro-psychopharmacol Biol Psychiatry. 1989;13(5):635-51.

Gomez-Vazquez ME, Hernandez-Salazar E, Hernandez-Jimenez A, Perez-Sanchez A, Zepeda-Lopez VA, Salazar-Paramo M. Clinical analgesic efficacy and side effects of dexmedetomidine in the early postoperative period after arthroscopic knee surgery. J Clin Anesth. 2007;19:576-82.

Yildiz M, Tavlan A, Tuncer S, Reisli R, Yosunkaya A, Otelcioglu S. Effect of dexmedetomidine on hemodynamic responses to laryngoscopy and intubation: perioperative hemodynamics and anesthetic requirements. Drugs R D. 2006;7:43-52.

Savola JM, Ruskoaho H, Puurunen J, Salonen JS, Karki NT. Evidence for medetomidine as a selective and potent agonist at alpha2-adrenoreceptors. J Autonomic Pharmacol. 1986;5:275-84.

Zalunardo M. Preoperative Clonidine attenuates stress response during emergence from anaesthesia. Journal of Clinical Anesthesia. 2000;12:343-9.

Reddy VS, Shaik NA, Donthu B, Sannala VK, Jangam V. Intravenous dexmedetomidine versus Clonidine for prolongation of bupivacaine spinal anesthesia and analgesia- A randomized double blind study. J Anaesthesiol clin Pharmacol. 2013;29:342-7.